Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Note
  • Published:

Comparison of the lateral tail vein and the retro-orbital venous sinus routes of antibody administration in pharmacokinetic studies

Abstract

In pharmacokinetic studies, intravenous (i.v.) administration of antibodies to mice is usually done via the lateral tail vein. This approach can cause stress to the mice and has a high rate of failure because it is challenging to perform correctly. Administration via the retro-orbital venous sinus has been suggested as a good alternative to tail vein i.v. administration of antibodies. Evidence is still needed, however, to determine whether the route of administration has an effect on the absorption or the pharmacokinetic activity of the injected antibody. The authors compared serum concentrations and pharmacokinetic parameters of a therapeutic antibody administered via tail vein injection or via retro-orbital injection. The findings suggest that there is no difference in the absorption or pharmacokinetic activity of therapeutic antibodies when administered via the lateral tail vein versus the retro-orbital venous sinus.

This is a preview of subscription content, access via your institution

Access options

Figure 1

Similar content being viewed by others

References

  1. Roopenian, D.C., Christianson, G.J. & Sproule, T.J. Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies. Methods Mol. Biol. 602, 93–104 (2010).

    Article  CAS  Google Scholar 

  2. Zhou, J., Mateos, F., Ober, R.J. & Ward, E.S. Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis. J. Mol. Biol. 345, 1071–1081 (2005).

    Article  CAS  Google Scholar 

  3. Vaccaro, C., Bawdon, R., Wanjie, S., Ober, R.J. & Ward, E.S. Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Proc. Natl. Acad. Sci. U.S.A. 103, 18709–18714 (2006).

    Article  CAS  Google Scholar 

  4. Petkova, S.B. et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int. Immunol. 18, 1759–1769 (2006).

    Article  CAS  Google Scholar 

  5. Ober, R.J., Radu, C.G., Ghetie, V. & Ward, E.S. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int. Immunol. 13, 1551–1559 (2001).

    Article  CAS  Google Scholar 

  6. Yardeni, T., Eckhaus, M., Morris, H.D., Huizing, M. & Hoogstraten-Miller, S. Retro-orbital injections in mice. Lab Anim. (NY) 40, 155–160 (2011).

    Article  Google Scholar 

  7. Price, J.E., Barth, R.F., Johnson, C.W. & Staubus, A.E. Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routes. Proc. Soc. Exp. Biol. Med. 177, 347–353 (1984).

    Article  CAS  Google Scholar 

  8. Steel, C.D., Stephens, A.L., Hahto, S.M., Singletary, S.J. & Ciavarra, R.P. Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model. Lab Anim. (NY) 37, 26–32 (2008).

    Article  Google Scholar 

  9. Schoell, A.R. et al. Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies. J. Am. Assoc. Lab. Anim. Sci. 48, 506–511 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. GV-SOLAS. Stellungnahme aus dem Ausschuss für Tierschutzbeauftragte zur Applikation in den retrobulbären Venenplexus bei Mäusen (2012).

  11. Russell, W.M.S. & Burch, R.L. The Principles of Humane Experimental Technique (Methuen, London, 1959).

    Google Scholar 

Download references

Acknowledgements

We thank Marco Friedrich for performing the animal studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela Schoch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schoch, A., Thorey, I., Engert, J. et al. Comparison of the lateral tail vein and the retro-orbital venous sinus routes of antibody administration in pharmacokinetic studies. Lab Anim 43, 95–99 (2014). https://doi.org/10.1038/laban.481

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/laban.481

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing